Latest filing published 21 Apr 2023 for Lipigon Phartmaceuticals AB, €9,284.
Insider track record
No signal scores available.
Johannes Hulthe: trading record in brief
Johannes Hulthe is a declared insider of Lipigon Phartmaceuticals AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 30 June 2022 to 21 April 2023, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 21 April 2023, the filings show a transaction worth €9,284 in Lipigon Phartmaceuticals AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Johannes Hulthe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ SEK 3.5018.8% of flowBTU (betald tecknad unit)ISIN SE0019914128FI:csv-8929ff6d25b18684efeb
- 199,998 shares@ SEK 2.15100.0% of flowBTA (betald tecknad aktie)ISIN SE0015382072FI:csv-11af6543a1f7a9864018
2 of 2 declarations